SRIT India Secures ₹128.93 Crore Healthcare Managed Services Order From Ooredoo
SRIT India has secured a multi-year healthcare managed services order from Ooredoo QPSC worth QR 50 million (₹128.93 crore). The contract spans 2 to 3 years and strengthens the company's international domain portfolio following strong Q2 FY27 operational growth.
Market snapshot: SRIT India Limited has secured an international contract valued at approximately QR 50 million (₹128.93 crore) from Qatari telecom and technology entity Ooredoo QPSC. The engagement mandates healthcare managed services implementation over a multi-year timeframe of 2 to 3 years.
Data Snapshot
- SRIT India secured a Healthcare Managed Services contract valued at QR 50 million (approx ₹128.93 crore) from Ooredoo QPSC, with an execution timeline of 2 to 3 years.
- SRIT India reported Q2 FY27 consolidated revenue from operations of ₹104.7 crore, up 29.0% YoY compared to ₹81.18 crore in Q2 FY26.
- SRIT India recorded consolidated Q2 FY27 Profit After Tax (PAT) of ₹13.74 crore, representing 38.2% YoY growth compared to ₹9.94 crore in Q2 FY26.
What's Changed
- Secured an international Healthcare Managed Services contract worth ₹128.93 crore from Ooredoo QPSC, boosting multi-year revenue visibility across a 2 to 3 year execution horizon.
- Q2 FY27 consolidated revenue expanded to ₹104.7 crore, demonstrating 29.0% YoY organic top-line expansion.
Key Takeaways
- The ₹128.93 crore contract win exceeds SRIT India's entire single-quarter revenue reported in Q2 FY27 (₹104.7 crore).
- The agreement locks in managed healthcare services revenue across a 2 to 3 year timeframe with a premier Middle Eastern enterprise.
- Complements strong operational execution established in Q2 FY27, where net profit rose 38.2% YoY to ₹13.74 crore.
SAHI Perspective
The contract win from Ooredoo QPSC provides substantial revenue predictability for SRIT India over the next 24 to 36 months. Given that the single contract value of ₹128.93 crore surpasses the company's Q2 FY27 quarterly revenue base of ₹104.7 crore, execution of this order strengthens cash flow visibility while solidifying SRIT India's specialized positioning in healthcare managed services across international markets.
Market Implications
The announcement validates SRIT India's execution capabilities in complex managed healthcare deployments abroad. With the contract spread over 2 to 3 years, annual revenue contributions will enhance top-line stability and operating margin leverage.
Trading Signals
Market Bias: Bullish
The ₹128.93 crore order win from Ooredoo QPSC provides multi-year revenue visibility, building on robust Q2 FY27 financial performance where consolidated revenue grew 29.0% YoY to ₹104.7 crore and net profit expanded 38.2% YoY to ₹13.74 crore.
Overweight: IT Services & Healthcare Managed Systems
Trigger Factors:
- Milestone execution timelines and revenue recognition updates from the Ooredoo project.
- Sustained operating profit margin stability in upcoming quarterly reporting cycles.
Time Horizon: Medium-term (3-12 months)
Industry Context
Managed IT services in healthcare demand specialized compliance and software integration capabilities. Cross-border contract awards from large regional telecommunications and technology conglomerates highlight expanding addressable markets for Indian specialized IT service providers.
Key Risks to Watch
- Execution risk across international healthcare managed service deliverables.
- Foreign exchange currency fluctuations between the Qatari Riyal and Indian Rupee.
Recent Developments
On November 13, 2026, SRIT India issued its operational commentary for H1 FY27, reporting consolidated Q2 FY27 revenue of ₹104.7 crore (up 29.0% YoY) and net profit of ₹13.74 crore (up 38.2% YoY), driven by improved execution efficiency and lower technical sub-contracting fees.
Closing Insight
Securing a major multi-year international healthcare contract anchors SRIT India's medium-term growth profile and operational credibility in overseas markets.
High Performance Trading with SAHI.
Disclaimer: This news section may include AI-generated or AI-assisted news, summaries, drafts, or insights. All content is subject to human review before publication. While we aim for accuracy, readers should independently verify information before relying on it.
Open Free AccountRelated
India Glycols Targets ₹400 Crore EBITDA In 4-5 Years And 10X Long-Term Growth
Jeena Sikho Lifecare Starts Operations at New Client Support Center in Noida
Dollar Industries Targets 11%-13% Revenue Growth And 11.5%-12.5% EBITDA Margin For FY27
India GDP Growth Outlook Supported by Capital Expenditure and Credit Expansion
Recent
India Glycols Targets ₹400 Crore EBITDA In 4-5 Years And 10X Long-Term Growth
Jeena Sikho Lifecare Starts Operations at New Client Support Center in Noida
Dollar Industries Targets 11%-13% Revenue Growth And 11.5%-12.5% EBITDA Margin For FY27
India GDP Growth Outlook Supported by Capital Expenditure and Credit Expansion
Waaree Energies Named Kiwa PVEL Top Performer For 5th Consecutive Year In 2026
Frequently Asked Questions (FAQs)
All topics
Click the link, confirm the box next to sahi.com is checked — ignore any other results.